Prognosis and personalized treatment prediction in TP53 -mutant hepatocellular carcinoma: an in silico strategy towards precision oncology
TP53 mutation is one of the most common genetic changes in hepatocellular carcinoma (HCC). It is of great clinical significance to tailor specialized prognostication approach and to explore more therapeutic options for TP53-mutant HCCs. In this study, a total of 1135 HCC patients were retrospectivel...
Gespeichert in:
Veröffentlicht in: | Briefings in bioinformatics 2021-05, Vol.22 (3) |
---|---|
Hauptverfasser: | , , , , , |
Format: | Artikel |
Sprache: | eng |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Schreiben Sie den ersten Kommentar!